Novartis said a pretax gain from the sale of its stake in a U.S. drug company and continued productivity improvement pushed third-quarter earnings 44% higher.
via WSJ.com: US Business http://ift.tt/1tc8bHC
via WSJ.com: US Business http://ift.tt/1tc8bHC
Nessun commento:
Posta un commento